HealthQuill India
India has destroyed 140,000 kilograms of narcotics worth 23 billion rupees — a record for the highest quantity of drugs crushed in a single day, according to the home minister.
Drugs Health Pharma

India cracks down on narcotics with a record one-day haul

HQ Team July 18, 2023: India has destroyed 140,000 kilograms of narcotics worth 23 billion rupees — a record for the highest quantity.

Read More
Global health bodies in more than 100 nations are uniting to vaccinate children after COVID-19 waves severed supplies, shuttered clinics, and overburdened health services.
Drugs Medical Pharma

UN-led ‘Big Catch-up’ to immunize kids after COVID-19 rampage

Global health bodies in more than 100 nations are uniting to vaccinate children after COVID-19 waves severed supplies, shuttered clinics, and overburdened health.

Read More
Record-breaking heat caused by greenhouse gases, ocean heat, and ocean acidification have resulted in glacial melts, a rise in sea levels, and human displacement last year,  according to a WMO report. 
Climate Drugs Health

Failing crops, melting glaciers, record-smashing heat in 2022: WMO

HQ Team April 22, 2023: Record-breaking heat caused by greenhouse gases, ocean heat, and ocean acidification have resulted in glacial melts, a rise.

Read More
Jubilant Ingrevia, an Indian public-listed company, has commissioned its new global-scale acetic anhydride plant at its facility in western India’s Bharuch.
Drugs Medical Pharma

Jubilant Ingrevia raises capacity of acetic anhydride plant

HQ Team April 18, 2023: Jubilant Ingrevia, an Indian public-listed company, has commissioned its new global-scale acetic anhydride plant at its facility in.

Read More
Health emergencies, prevention, preparedness, and response, will top the agenda at the second Health Working Group meeting of G20 member nations during the two-day meeting starting in India today.
Drugs Health Pharma

Prevention, preparedness, response to top G20 health group agenda

HQ Team April 17, 2023: Health emergencies, prevention, preparedness, and response, will top the agenda at the second Health Working Group meeting of G20 member.

Read More
Astec LifeSciences, a subsidiary of Godrej Agrovet, opened its research and development centre in Rabale, Maharashtra, India, to expand into the contract development and manufacturing business in the chemical industry.
Drugs Medical Pharma

India’s Astec LifeSciences to tap contract development market

HQ Team April 11, 2023: Astec LifeSciences, a subsidiary of Godrej Agrovet, opened its research and development centre in Rabale, Maharashtra, India, to.

Read More
Larsen and Toubro, one of the world’s top construction companies, got an order worth up to INR 25 billion ($305 million) to set up two plants in northern India.
Climate Health Pharma

India’s L&T bags hydrocarbon order worth up to $305 million 

HQ Team April 10, 2023: Larsen and Toubro, one of the world’s top construction companies, got an order worth up to INR 25.

Read More
India’s Tata Power Company’s distribution arm has signed a pact with ADB for access to debt capital worth INR 1.5 billion ($18.2 million) to increase power supply in the nation’s capital, New Delhi.
Climate Health Pharma

India’s Tata Power secures $20.2 million NCD loan from ADB

HQ Team April 10, 2023: India’s Tata Power Company’s distribution arm has signed a pact with ADB for access to debt capital worth.

Read More
India’s federal government has told state authorities to identify emergency COVID-19 hotspots and ramp up testing, vaccination, and hospital infrastructure as the virus spreads in the South Asian nation.
Health Medical Pharma

India tells states to ramp up COVID-19 emergency procedures 

 HQ Team April 8, 2023: India’s federal government has told state authorities to identify emergency COVID-19 hotspots and ramp up testing, vaccination, and.

Read More
Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne Pharma’s U.S. generic prescription portfolio.
Drugs Health Medical Pharma

Dr. Reddy’s completes Mayne Pharma’s U.S. portfolio buyout

H.Q. Team April 7, 2023: Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne.

Read More